Asthma and COPD are widespread chronic respiratory diseases with major social and economic impacts. Traditional one-size-fits-all treatments often manage symptoms without improving underlying health. RESPIRE-EXCEL aims to address this through individualized precision medicine.
The project trains a new generation of translational and medical scientists with multidisciplinary, cross-sector skills to advance precision medicine for asthma and COPD. The RESPIRE-EXCEL consortium brings together academic, industrial, and societal partners across Europe, including the European Lung Foundation and the European Respiratory Society.